Global Health Clinics Ltd. announces management changes at its Wonder Scientific Division. Wonder Scientific was acquired by the Company on January 20, 2021 is focused on sourcing and securing access to federally licensed work &bench space required for formulation and manufacturing work in the B2B sales channels of the active pharmaceutical ingredients (API) industry, including psilocybin. In order to align the strategic goals of the Company and Wonder Scientific in the biopharmaceutical industry, the Company has made significant management changes. Tegan Adams, a co-founder of Wonder Scientific, is no longer with the Company or Wonder Scientific. Istok Nahtigal and Angela Caruk, former consults of Wonder Scientific, are also no longer consulting for Wonder Scientific. The Company announced that its Wonder Scientific division will now be led by Dr. Brian Jahns. Dr. Jahns brings more than 20 years of business leadership and biopharmaceutical expertise to his role in overseeing the overall business development of Wonder Scientific, including its key corporate objectives of sourcing and securing access to federally licensed work and bench space required for formulation and manufacturing work in the business-to-business sales channels of the industry. Importantly, Dr. Jahns will focus on the custom creation of naturally derived APIs to supply the growing global clinical and commercial demand for psychedelics. Dr. Jahns has held senior leadership roles in the biopharmaceutical industry, including ZYUS, Trillium Therapeutics and Roche Canada, and has been deeply involved in the successful launch and growth of several successful compounds, including antiviral agents, transplant drugs and anticancer biologics, and developing targeted therapies for previously untreated diseases.